Evogene EVGN reported its Q3 earnings results on Wednesday, November 15, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Evogene beat estimated earnings by 50.0%, reporting an EPS of $-0.08 versus an estimate of $-0.16.
Revenue was up $3.30 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 8.59% increase in the share price the next day.
Here's a look at Evogene's past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.16 | -0.20 | -0.20 |
| EPS Actual | -0.17 | -0.15 | -0.07 | -0.16 |
| Revenue Estimate | 880K | 870K | 420K | 100K |
| Revenue Actual | 654K | 641K | 660K | 466K |
To track all earnings releases for Evogene visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
